Year: 2019
Type: dissertation
Abstract: Tau protein has been identified as an important player in the development and progression of several neurodegenerative disorders, commonly addressed to as Tauopathies. Tauopathies comprise more than 20 neurodegenerative disorders, being the most common Alzheimer’s disease. These disorders are characterized by the aggregation and accumulation of insoluble hyperphosphorylated Tau protein in the brain. Despite the increasing number of cases, the pathologic mechanism of Tauopathies is not yet clear and therefore no efficacious treatment has been found. In fact, the treatments administered can only ameliorate the symptoms and do not affect the progression of the diseases. Accordingly, targeting Tau for Alzheimer’s disease is one of the largest unmet medical needs of our time.Recent studies uncovered a presynaptic role for Tau, as well as its correlation with the early symptoms of Tauopathies. At the presynaptic level, Tau is able to impair synaptic vesicles’ mobility and release through the interaction with Syngr3, and these events precede neurodegeneration and Tauopathies onset.In this report, we aimed to further study Tau and Syngr3 interaction in vivo and to develop and optimize both biochemical (AlphaLISA) and cell-based (NanoBiT) assays to support a drug discovery screening campaign, targeting Tau-Syngr3 interaction for the treatment of Tauopathies. The in vivo studies supported the interaction between Tau and synaptic vesicles, in a Tauopathy mouse model. Both biochemical and cell-based assays could potentially provide an insight of which domain(s) of Syngr3 is/are interacting with Tau, however, the results are unclear. Furthermore, the cell-based assay is consistent and robust and can be used for screening compounds in the pursuit of molecules that are able to disrupt Tau-Syngr3 interaction.
Author: Ana Filipa Martins de Oliveira
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W3157263170
